Massachusetts Financial Services’s Regenxbio RGNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $168K | Buy |
+20,500
| New | +$168K | ﹤0.01% | 878 |
|
|
2023
Q3 | – | Sell |
-23,273
| Closed | -$465K | – | 865 |
|
|
2023
Q2 | $465K | Sell |
23,273
-26,184
| -53% | -$523K | ﹤0.01% | 789 |
|
|
2023
Q1 | $935K | Buy |
49,457
+4,911
| +11% | +$92.9K | ﹤0.01% | 767 |
|
|
2022
Q4 | $1.01M | Buy |
44,546
+943
| +2% | +$21.4K | ﹤0.01% | 774 |
|
|
2022
Q3 | $1.15M | Buy |
+43,603
| New | +$1.15M | ﹤0.01% | 770 |
|